Related Experiment Video
Updated: Aug 7, 2026
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Recent developments in delivery of nucleic acid-based antiviral agents
1Chemical and Biological Defence Section, Defence R & D Canada - Suffield, Ralston, Alberta, Canada.
Current Pharmaceutical Design
|June 22, 2006
Summary
Gene-based antiviral drugs show promise but face delivery challenges. Encapsulation in liposomes or viral vectors enhances efficacy, though viral vectors raise safety concerns.
Area of Science:
- Molecular Biology
- Virology
- Pharmacology
Background:
- Gene-based drugs offer novel antiviral strategies targeting viral genomics and replication.
- Challenges include intracellular delivery and nuclease degradation, limiting therapeutic efficacy.
Purpose of the Study:
- To review advancements in delivery systems for gene-based antiviral drugs.
- To highlight methods enhancing drug targeting to viral replication sites and minimizing toxicity.
Main Methods:
- Evaluation of liposome encapsulation for gene-based drug delivery.
- Assessment of viral vectors for enhanced gene-based drug delivery and expression.
Main Results:
- Liposomes and viral vectors significantly improve gene-based drug delivery and antiviral efficacy.
- Viral vector therapy generally yields higher expression but poses safety concerns.
Conclusions:
- Delivery systems are crucial for overcoming gene-based antiviral drug limitations.
- Ongoing research aims to optimize targeted delivery and mitigate adverse effects for safer, more effective antiviral therapies.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
02:27DNA Base Pairing
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...